298 related articles for article (PubMed ID: 31888831)
1. Chitosan capped pH-responsive hollow mesoporous silica nanoparticles for targeted chemo-photo combination therapy.
Yan T; He J; Liu R; Liu Z; Cheng J
Carbohydr Polym; 2020 Mar; 231():115706. PubMed ID: 31888831
[TBL] [Abstract][Full Text] [Related]
2. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
3. Fabricating polydopamine-coated MoSe
Chai S; Kan S; Sun R; Zhou R; Sun Y; Chen W; Yu B
Int J Nanomedicine; 2018; 13():7607-7621. PubMed ID: 30510420
[TBL] [Abstract][Full Text] [Related]
4. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer.
Niu S; Zhang X; Williams GR; Wu J; Gao F; Fu Z; Chen X; Lu S; Zhu LM
Acta Biomater; 2021 May; 126():408-420. PubMed ID: 33731303
[TBL] [Abstract][Full Text] [Related]
5. Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release.
Jiao J; Li X; Zhang S; Liu J; Di D; Zhang Y; Zhao Q; Wang S
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():26-33. PubMed ID: 27287095
[TBL] [Abstract][Full Text] [Related]
6. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
[TBL] [Abstract][Full Text] [Related]
7. Facile synthesis by a covalent binding reaction for pH-responsive drug release of carboxylated chitosan coated hollow mesoporous silica nanoparticles.
Liu Q; Wang J; Yang L; Xia X; Wang M; Chen S; Zhu R; Wang Q; Wu X; Wang S
IET Nanobiotechnol; 2018 Jun; 12(4):446-452. PubMed ID: 29768228
[TBL] [Abstract][Full Text] [Related]
8. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery.
Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R
ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422
[TBL] [Abstract][Full Text] [Related]
9. Bovine serum albumin-based and dual-responsive targeted hollow mesoporous silica nanoparticles for breast cancer therapy.
Zhang Y; Ye Z; He R; Li Y; Xiong B; Yi M; Chen Y; Liu J; Lu B
Colloids Surf B Biointerfaces; 2023 Apr; 224():113201. PubMed ID: 36822117
[TBL] [Abstract][Full Text] [Related]
10. Albumin-MnO
Fang J; Wang Q; Yang G; Xiao X; Li L; Yu T
Colloids Surf B Biointerfaces; 2019 Jul; 179():250-259. PubMed ID: 30978612
[TBL] [Abstract][Full Text] [Related]
11. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
[TBL] [Abstract][Full Text] [Related]
12. Photothermally controlled drug release system with high dose loading for synergistic chemo-photothermal therapy of multidrug resistance cancer.
Wu X; Liu J; Yang L; Wang F
Colloids Surf B Biointerfaces; 2019 Mar; 175():239-247. PubMed ID: 30540971
[TBL] [Abstract][Full Text] [Related]
13. pH-Sensitive mesoporous silica nanoparticles for chemo-photodynamic combination therapy.
Yan T; Cheng J; Liu Z; Cheng F; Wei X; He J
Colloids Surf B Biointerfaces; 2018 Jan; 161():442-448. PubMed ID: 29121617
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid targeted and pH-responsive nanocarriers based on hollow mesoporous silica nanoparticles for chemo-photodynamic combination therapy.
Chen K; Chang C; Liu Z; Zhou Y; Xu Q; Li C; Huang Z; Xu H; Xu P; Lu B
Colloids Surf B Biointerfaces; 2020 Oct; 194():111166. PubMed ID: 32521461
[TBL] [Abstract][Full Text] [Related]
15. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
[TBL] [Abstract][Full Text] [Related]
16. Construction and performance evaluation of pH-responsive oxidized hyaluronic acid hollow mesoporous silica nanoparticles.
Enyu X; Xinbo L; Xuelian C; Huimin C; Yin C; Yan C
Int J Biol Macromol; 2024 Feb; 257(Pt 1):128656. PubMed ID: 38065461
[TBL] [Abstract][Full Text] [Related]
17. A targeted drug delivery system based on folic acid-functionalized upconversion luminescent nanoparticles.
Liang X; Fan J; Zhao Y; Cheng M; Wang X; Jin R; Sun T
J Biomater Appl; 2017 Apr; 31(9):1247-1256. PubMed ID: 28350205
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
Wu J; Tang C; Yin C
Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
[TBL] [Abstract][Full Text] [Related]
19. Thermoresponsive polymer gated and superparamagnetic nanoparticle embedded hollow mesoporous silica nanoparticles as smart multifunctional nanocarrier for targeted and controlled delivery of doxorubicin.
Asghar K; Qasim M; Dharmapuri G; Das D
Nanotechnology; 2020 Nov; 31(45):455604. PubMed ID: 32311684
[TBL] [Abstract][Full Text] [Related]
20. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy.
Liu J; Luo Z; Zhang J; Luo T; Zhou J; Zhao X; Cai K
Biomaterials; 2016 Mar; 83():51-65. PubMed ID: 26773665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]